NDC 50268-060-11 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50268-060
- Requested NDC
- 50268-060-11
- Package NDCs from labels
- 50268-060-11, 50268-060-15
- Manufacturer
- AvPAK
- Effective date
- 2018-02-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir - AvPAK | AvPAK | 2018-02-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50268-060-11 | EA - Each | 50268-060 | ec269ccf-d8ed-4a0f-b0c0-09d596afd510 | 1 | 2015-04-03 |
| 50268-060-15 | EA - Each | 50268-060 | 8eed6504-b765-46f2-a37a-d8d48bfd5aed | 1 | 2013-08-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Acyclovir | ACTIVE INGREDIENT | X4HES1O11F | ACYCLOVIR (ACYCLOVIR) CAPSULE [AVPAK] | 2 | |
| Acyclovir | ACTIVE MOIETY | X4HES1O11F | ACYCLOVIR (ACYCLOVIR) CAPSULE [AVPAK] | 2 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ACYCLOVIR (ACYCLOVIR) CAPSULE [AVPAK] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ACYCLOVIR (ACYCLOVIR) CAPSULE [AVPAK] | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | ACYCLOVIR (ACYCLOVIR) CAPSULE [AVPAK] | 2 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | ACYCLOVIR (ACYCLOVIR) CAPSULE [AVPAK] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | 83e82707-85b6-2fea-e053-2991aa0a99ef | 2026-11-04 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | 331fe0bd-6bb2-4337-8faa-d0c82ff54dc7 | 2026-10-30 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 8d4c9317-7475-42ec-a0b0-d43929114369 | 2026-10-12 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | American Health Packaging | 05f42300-2a06-45f1-a9b9-6e5c84ae58ec | 2026-09-29 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | 4a76b92b-f93f-4965-b2b2-4db8f9183306 | 2026-09-18 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | a1086845-ba08-4fb2-81dc-aea9c68bf2c3 | 2026-09-10 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | REMEDYREPACK INC. | c1744e01-0e40-4851-8ffc-c3bf29dd7c2b | 2026-08-31 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals, Inc. | 5176c7f9-9076-4797-e054-00144ff8d46c | 2026-08-27 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | e5e99a6b-79a6-7fdb-e053-2a95a90a8563 | 2026-08-26 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | 58dc1402-6098-9cb3-e063-6294a90a062b | 2026-08-19 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Northwind Health Company, LLC | 50c58161-3944-7367-e063-6394a90a6286 | 2026-08-19 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Cardinal Health 107, LLC | 4cc7d67f-35fa-4238-a581-4810645083cf | 2026-08-13 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | c | 59007780-d736-4195-a204-7f85a709ed46 | 2026-08-12 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 0de2f5c7-9e75-4bdf-9c28-e026cc6694b4 | 2026-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | 86c43bdf-c5bf-47cd-8dfd-811263825878 | 2026-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | 2026-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 736679be-469e-4bdb-8e15-b10751c3dd60 | 2026-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 38547daa-7d2f-4a7b-84d3-6e164984f958 | 2026-07-17 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Major Pharmaceuticals | 9b254eed-8ea1-469b-bf27-f5670cd99e8d | 2026-07-14 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | ATLANTIC BIOLOGICALS CORP. | da5a809c-6ddc-4609-9a34-ccb3d2d43976 | 2026-07-10 | Warnings, Adverse reactions | X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.